While activated GPIIb/IIIa has been linked to the occurrence of ischemic outcomes following peripheral endovascular interventions [11], elevated sCD40L may predict future myocardial infarction and death in ACS patients [20, 21]. This evidence concerns the gene ITGA2B and myocardial infarction.